Skip to main content

HEMOSNOW: A revolution in haemostatic technology to stop bleeding in delicate surgery and enhance patient recovery

Project description

Helping surgeons to stop excessive bleeding

In major surgery, excessive blood loss is associated with longer hospital stays, delayed recovery and increased mortality. Haemostatic agents can be used to control bleeding. However, most haemostats currently used by surgeons have lengthy preparation times, are difficult to apply and stick to surgical instruments limiting their suitable application. In this context, the EU-funded HEMOSNOW project will conduct the clinical study and upscale production to commercialise a unique haemostatic powder formulation capable of stopping minimum (oozing) and mild (pooling) bleeding (level 1 & 2 bleeding on the SPOTGRADE scale). It is a collagen-based powder that is ready to use and stops bleeding within 6 minutes.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 50 000,00
8, Allee Irene Joliot Curie
69800 Saint-priest

See on map

Auvergne-Rhône-Alpes Rhône-Alpes Rhône
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00